PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Phantom Lord]

Form 13G is filed to report a beneficial ownership of an "equity security" of more than 5% as required by the securities exchange act of 1934. It isn't just to report common stock. In the exchange act "equity security" is defined in part to include "any security convertible, with or without consideration into such a security, or carrying any warrant or right to subscribe to or purchase such a security." HERE is the full definition. So schedule 13D and 13G include all shares of common stock, warrants, and convertible securities. That's why they have the footnotes detailing exactly what the reported number includes. If it included actual shares of common stock it should have been broken down in the footnote. I have seen some filings that didn't do a full breakdown but that is a rare occurrence. At least in my experience.

Fintel just pulls the numbers from the filings. In this case the 13G. They don't take into account if the number includes any warrants or other convertible securities. They are just aggregating the info so you can get a rough overview of who is holding that particular company's securities. You have to read the actual filing to get the full picture.